» Articles » PMID: 12467749

Genotype-phenotype Correlations in X-linked Myotubular Myopathy

Overview
Specialty Neurology
Date 2002 Dec 7
PMID 12467749
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

X-linked myotubular myopathy is a severe congenital myopathy that presents in the neonatal period with profound hypotonia and an inability to establish spontaneous respiration. Usually death occurs in infancy from respiratory failure. However, there is phenotypic variability; a number of affected boys have achieved respiratory independence and become ambulatory. Disease-causing mutations have been identified throughout the MTM1 gene on Xq28. MTM1 encodes the protein myotubularin, which is expressed ubiquitously. The main objectives of this study were to establish whether the nature or site of the mutation in the MTM1 gene could predict severity of the disease and to investigate whether early intensive clinical intervention facilitated survival until spontaneous improvement occurred. An association was demonstrated between the presence of a non-truncating mutation of the MTM1 gene and the mild phenotype. However, many non-truncating mutations were also seen in association with the severe phenotype and these were not confined to recognized functional domains of the protein. This suggests that the use of mutation analysis to predict prognosis in the early period following diagnosis is limited. Unexpectedly, over 50 patients surviving for more than 1 year were identified in this study. Further information obtained on 40 of these cases revealed that 50% were receiving 24-h ventilatory support, while 27% were ventilated at night only. The high survival rate for this disorder therefore reflects intensive medical intervention without which the majority of these boys would not survive.

Citing Articles

Gene therapy for genetic diseases: challenges and future directions.

Qie B, Tuo J, Chen F, Ding H, Lyu L MedComm (2020). 2025; 6(2):e70091.

PMID: 39949979 PMC: 11822459. DOI: 10.1002/mco2.70091.


An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience.

Graham R, Amin R, Demirel N, Edel L, Lilien C, MacBean V Respir Res. 2024; 25(1):342.

PMID: 39285418 PMC: 11406763. DOI: 10.1186/s12931-024-02966-0.


A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.

Souza P, Haselkorn T, Baima J, Oliveira R, Hernandez F, Birck M Orphanet J Rare Dis. 2024; 19(1):188.

PMID: 38715109 PMC: 11077759. DOI: 10.1186/s13023-024-03144-7.


Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.

Kusikova K, Soltysova A, Ficek A, Feichtinger R, Mayr J, Skopkova M Genes (Basel). 2023; 14(12).

PMID: 38136996 PMC: 10742680. DOI: 10.3390/genes14122174.


An unusual way to improve lung function in congenital myopathies: the power of singing.

Valentino M, Annunziata A, Atripaldi L, Fiorentino G Acta Myol. 2023; 42(2-3):86-88.

PMID: 38090546 PMC: 10712659. DOI: 10.36185/2532-1900-357.